Search research articles
Contact Us
Filters
Showing results (131-140 of 166) with videos related to
Page
of 17
Sort By:
ESMO Open
|
February 26, 2022
Drug-induced interstitial lung disease during cancer therapies: expert opinion on diagnosis and treatment
P Conte, P A Ascierto, G Patelli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 1997
Efficacy, toxicity, and applicability of high-dose sequential chemotherapy as adjuvant treatment in operable breast cancer with 10 or more involved axillary nodes: five-year results
A M Gianni, S Siena, M Bregni, et al.
ESMO Open
|
August 13, 2022
Pooled analysis of drug-related interstitial lung disease and/or pneumonitis in nine trastuzumab deruxtecan monotherapy studies
C A Powell, S Modi, H Iwata, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 19, 2011
T-cell therapy for EBV-associated nasopharyngeal carcinoma: preparative lymphodepleting chemotherapy does not improve clinical results
S Secondino, M Zecca, L Licitra, et al.
Cancer Gene Therapy
|
January 23, 1999
Gene transfer into human dendritic antigen-presenting cells by vaccinia virus and adenovirus vectors
M Di Nicola, S Siena, M Bregni, et al.
British Journal of Cancer
|
November 28, 2007
Association of progression-free survival with patient-reported outcomes and survival: results from a randomised phase 3 trial of panitumumab
S Siena, M Peeters, E Van Cutsem, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 6, 2007
An open-label, single-arm study assessing safety and efficacy of panitumumab in patients with metastatic colorectal cancer refractory to standard chemotherapy
E Van Cutsem, S Siena, Y Humblet, et al.
Blood
|
June 5, 2001
H4(D10S170), a gene frequently rearranged in papillary thyroid carcinoma, is fused to the platelet-derived growth factor receptor beta gene in atypical chronic myeloid leukemia with t(5;10)(q33;q22)
J Schwaller, E Anastasiadou, D Cain, et al.
ESMO Open
|
April 30, 2021
Patient-reported outcomes from STARTRK-2: a global phase II basket study of entrectinib for ROS1 fusion-positive non-small-cell lung cancer and NTRK fusion-positive solid tumours
L Paz-Ares, F Barlesi, S Siena, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 14, 2006
Phase II study of cetuximab in combination with FOLFIRI in patients with untreated advanced gastric or gastroesophageal junction adenocarcinoma (FOLCETUX study)
C Pinto, F Di Fabio, S Siena, et al.
Page
of 17
Search research articles
Search
Showing results (131-140 of 166) with videos related to
Sort By:
Page
of 17
ESMO Open
|
February 26, 2022
Drug-induced interstitial lung disease during cancer therapies: expert opinion on diagnosis and treatment
P Conte, P A Ascierto, G Patelli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 1997
Efficacy, toxicity, and applicability of high-dose sequential chemotherapy as adjuvant treatment in operable breast cancer with 10 or more involved axillary nodes: five-year results
A M Gianni, S Siena, M Bregni, et al.
ESMO Open
|
August 13, 2022
Pooled analysis of drug-related interstitial lung disease and/or pneumonitis in nine trastuzumab deruxtecan monotherapy studies
C A Powell, S Modi, H Iwata, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 19, 2011
T-cell therapy for EBV-associated nasopharyngeal carcinoma: preparative lymphodepleting chemotherapy does not improve clinical results
S Secondino, M Zecca, L Licitra, et al.
Cancer Gene Therapy
|
January 23, 1999
Gene transfer into human dendritic antigen-presenting cells by vaccinia virus and adenovirus vectors
M Di Nicola, S Siena, M Bregni, et al.
British Journal of Cancer
|
November 28, 2007
Association of progression-free survival with patient-reported outcomes and survival: results from a randomised phase 3 trial of panitumumab
S Siena, M Peeters, E Van Cutsem, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 6, 2007
An open-label, single-arm study assessing safety and efficacy of panitumumab in patients with metastatic colorectal cancer refractory to standard chemotherapy
E Van Cutsem, S Siena, Y Humblet, et al.
Blood
|
June 5, 2001
H4(D10S170), a gene frequently rearranged in papillary thyroid carcinoma, is fused to the platelet-derived growth factor receptor beta gene in atypical chronic myeloid leukemia with t(5;10)(q33;q22)
J Schwaller, E Anastasiadou, D Cain, et al.
ESMO Open
|
April 30, 2021
Patient-reported outcomes from STARTRK-2: a global phase II basket study of entrectinib for ROS1 fusion-positive non-small-cell lung cancer and NTRK fusion-positive solid tumours
L Paz-Ares, F Barlesi, S Siena, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 14, 2006
Phase II study of cetuximab in combination with FOLFIRI in patients with untreated advanced gastric or gastroesophageal junction adenocarcinoma (FOLCETUX study)
C Pinto, F Di Fabio, S Siena, et al.
Page
of 17